Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

50
Stock Market News For Jul 20, 2018

2018-07-20 zacks
Markets finished sharply lower on Thursday, led by a selloff in financials, as President Donald Trump criticized the Fed saying that he wasn’t thrilled about the rate hikes. Also, trade war fears once again escalated as worries that the European Union (EU) could impose retaliatory tariffs on U.S imports dented investors’ confidence.
BAC C MS.PRE MS.PRF MS.PRG MS.PRA BAC GATX MS.PRI MS.PRK MS GMTA GMT

8
GATX Corp's (GATX) Q2 Earnings & Revenues Surpass Estimates

2018-07-20 zacks
GATX Corporation (GATX - Free Report) performed impressively in the second quarter of 2018, reporting better-than-expected earnings per share and revenues. The company’s earnings (excluding 15 cents from non-recurring items) of $1.16 per share surpassed the Zacks Consensus Estimate of 92 cents. However, the bottom line decreased 12.1% year over year due to higher costs. Expenses pertaining to the closure of a railcar maintenance facility in Germany weighed on the bottom line in the quarter under review.
GATX KDP AAL JBLU GMTA NSC GMT

0
GATX Corporation (GATX) CEO Brian Kenney on Q2, 2018 Results - Earnings Call Transcript

2018-07-19 seekingalpha
Good day, and welcome to the GATX Second Quarter Conference Call. Today’s conference is being recorded.
GATX GMTA GMT

0
GATX Corporation Reports 2018 Second-Quarter Results

2018-07-19 globenewswire
CHICAGO, July 19, 2018 (GLOBE NEWSWIRE) -- GATX Corporation (NYSE:GATX) today reported 2018 second quarter net income of $38.8 million or $1.01 per diluted share, compared to net income of $53.4 million or $1.35 per diluted share in the second quarter of 2017. Net income for the first six months of 2018 was $115.1 million or $2.99 per diluted share, compared to $110.9 million or $2.79 per diluted share in the prior year period.
GATX GMTA GMT

0
TRTN or GATX: Which Is the Better Value Stock Right Now?

2018-07-18 zacks
Investors looking for stocks in the Transportation - Equipment and Leasing sector might want to consider either Triton International (TRTN - Free Report) or Gatx (GATX - Free Report) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.
GATX TRTN

0
JetBlue June Traffic Data Solid, Q2 Fuel Cost View Bleak

2018-07-13 zacks
JetBlue Airways Corporation (JBLU - Free Report) posted impressive traffic results for June. Traffic measured in revenue passenger miles (RPMs), increased 7.8% year over year to 4.4 billion. Consolidated capacity (or available seat miles/ASMs) also expanded 5.9% to 5.06 billion on a year-over-year basis. Load factor or percentage of seats filled by passengers improved 150 basis points (bps) to 87% in the month as traffic growth outpaced capacity expansion.
GATX EXPD AAWW JBLU GMTA GMT

0
Q2 Earnings Optimism Lifts S&P 500 to 5-Month High: 5 Gainers

2018-07-11 zacks
On Jun 11, U.S. stocks closed in the black for the fourth successive session. Once again, optimism over the second-quarter earnings season triumphed over trade tensions. Investors widely expect upcoming results to sustain the strong momentum created during the first-quarter earnings season.
GATX MLNX PGR CSX GMTA GMT CE

0
Allegiant's (ALGT) Traffic & Load Factor Increase in June

2018-07-10 zacks
Allegiant Travel Company (ALGT - Free Report) reported impressive traffic numbers for June. Traffic for the total system (including scheduled service and fixed fee contract), measured in revenue passenger miles (RPMs), increased 9.5% on a year-over-year basis to 1.22 billion. System capacity, calculated in available seat miles (ASMs), improved 8.8% to 1.43 billion. With traffic growth outpacing capacity expansion, load factor (percentage of seats filled with passengers) inched up 60 basis points year over year to 85.
GATX EXPD AAWW GMTA ALGT GMT

1
Alaska Air (ALK) Unit Begins New York-San Jose Operation

2018-07-09 zacks
Alaska Air Group, Inc.’s (ALK - Free Report) subsidiary Alaska Airlines has launched a nonstop service between Mineta San Jose International Airport and New York’s John F. Kennedy International Airport (JFK). The daily roundtrips have been operational since Jul 6. The carrier is utilizing the A320 aircraft to ply on the routes. With the expanded JFK service, Alaska Airlines now operates 15 flights per day to the airport from six West Coast cities of Las Vegas, Los Angeles, Portland,San Francisco, San Jose and Seattle.
GATX EXPD AAWW GMTA ALK GMT

0
Gol Linhas Posts a Rise in June Traffic, Guides for Q2

2018-07-06 zacks
Gol Linhas Aereas Inteligentes S.A. (GOL - Free Report) reported unimpressive traffic figures for June 2018, with load factor (percentage of seats filled by passengers) declining as capacity expansion outweighed traffic growth. Traffic, measured in revenue passenger kilometers (RPK), increased 4.6% to 2.81 billion. While domestic RPK climbed 6.7%, international RPK plunged 16.6%. On a year-over-year basis, consolidated capacity (or available seat kilometers/ASKs) expanded 4.
GATX EXPD AAWW GMTA GMT

0
Ryanair Holdings' June Traffic Rises 7% Amid Labor Unrest

2018-07-06 zacks
Ryanair Holdings plc (RYAAY - Free Report) reported impressive traffic figures for June owing to low air fares. Notably, traffic increased 7% year over year to 12.6 million in the month. In fact, the passenger count in June was the highest so far (April, May and June) at Ryanair in fiscal 2019. Passenger count in April and May were 12.3 million and 12.5 million, respectively. We note that Ryanair’s fiscal year ends on Mar 31.
GATX RYAOF CSX RYAAY GMTA NSC GMT

0
GATX Corporation Sets Date for 2018 Second Quarter Earnings Release and Conference Call

2018-07-06 globenewswire
CHICAGO, July 06, 2018 (GLOBE NEWSWIRE) -- GATX Corporation (NYSE:GATX) announced that it will report results for the 2018 second quarter prior to market open on Thursday, July 19, 2018. GATX will hold a conference call to review the results later that morning. Investors may listen to the call via telephone or over the Internet as follows:
GATX GMTA GMT

1
Zacks Industry Outlook Highlights: Ryder, GATX, Herc, Trinity and Triton

2018-07-06 zacks
Chicago, IL – July 6, 2018 – Today, Zacks Equity Research discusses Computer - Storage Devices, including Ryder System, Inc. (R - Free Report) , GATX Corp. (GATX - Free Report) , Herc Holdings Inc. (HRI - Free Report) , Trinity Industries, Inc. (TRN - Free Report) and Triton International Limited (TRTN - Free Report) .
GATX DB R ELVT GMTA TRN TRTN HRI GMT

1
Equipment & Leasing Transports' Outlook: Smooth Road Ahead

2018-07-05 zacks
The Zacks Transportation - Equipment and Leasing industry offers equipment financing, leasing and supply chain management services and includes aircraft and railcar lessors among others. The industry is currently in good shape thanks to a buoyant U.S. economy. Consumer confidence is critical to the growth of this industry. This is because an upbeat economy increases consumer confidence leading to increased propensity to spend.
GATX R GMTA TRN TRTN HRI GMT

2
Delta's (DAL) June Traffic Rises, Q2 Earnings View Intact

2018-07-04 zacks
Delta Air Lines, Inc. (DAL - Free Report) reported traffic figures for June. Traffic, measured in revenue passenger miles (RPMs), came in at 21.45 million, up 3% year over year. Consolidated capacity (or available seat miles/ASMs) also expanded 3% to 24.23 million on a year-over-year basis. As traffic growth was commensurate with capacity expansion, load factor in the month remained flat. Additionally, the Atlanta, GA-based airline recorded an 81.
BLT BHPBF GATX EXPD AAWW BHP BBL BHP GMTA BHPLF DAL GMT

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...